Neurotransmitters in Health and Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 276
Special Issue Editors
Interests: neurotransmitter; dopamine; addiction research
Special Issue Information
Dear Colleagues,
Neurotransmitters are chemical messengers that convey chemical signals from one neuron to another cell, such as a nerve cell, muscle cell or gland. Structurally, neurotransmitters are tyopically amino acids, monoamines or peptides, and they can be functionally classified into inhibitory, such as GABA and dopamine, and excitatory, such as glutamate and acetylcholine; however, they can also be classified into neurohormones, including corticotropin-releasing factor, arginine vasopressin and oxytocin, and neuromodulators, including noradrenaline, serotonin and histamine. Under physiological conditions, neurotransmitters modulate endocrine, autonomic and behavioral processes to maintain the homeostasis of the body, but their dysbalance may contribute to the pathogenesis of psychiatric disorders, such as anxiety, depression and substance use disorder, or neurological diseases, such as Alzheimers’s, Parkinson’s and Huntington’s disease. In this Special Issue of Biomedicines, I would like to invite you to share your recent research in the form of a review or original article addressing the role of neurotransmitters in health and disease.
Dr. Zsolt Bagosi
Dr. Krisztina Csabafi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurotransmitters
- GABA
- dopamine
- glutamate
- acetylcholine
- neurohormones
- neuromodulators
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
